Riparian Pharmaceuticals, Inc.

Boston, MA 02134

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $2.67MM
First Award Date 08/15/13
Most Recent Award Date 06/01/17

Key Personnel

Last Name Name Awards Contact
Adams William James Adams 6
Garcia-Cardena Guillermo Garcia-Cardena 6

6 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 06/01/17 - 05/31/18

? DESCRIPTION (provided by applicant): Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis Cardiovascular disease is the leading cause of morbidity and mortality in the world. In particular, atherosclerosis is a life-threatening disease strongly associated with risk factors such as elevated cholesterol levels, high blood pressur...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-16-288
Budget: 03/15/17 - 05/31/17

? DESCRIPTION (provided by applicant): Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis Cardiovascular disease is the leading cause of morbidity and mortality in the world. In particular, atherosclerosis is a life-threatening disease strongly associated with risk factors such as elevated cholesterol levels, high blood pressur...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic: PA-15-269
Budget: 09/01/16 - 05/31/17

? DESCRIPTION (provided by applicant): Therapeutic Reversal of Endothelial Dysfunction in Atherogenesis Cardiovascular disease is the leading cause of morbidity and mortality in the world. In particular, atherosclerosis is a life-threatening disease strongly associated with risk factors such as elevated cholesterol levels, high blood pressur...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-12-089
Budget: 09/15/14 - 12/31/14

DESCRIPTION (provided by applicant): Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis Cardiovascular disease is the leading cause of morbidity and mortality in the United States and is an emerging epidemic world-wide. In particular, atherosclerosis is a life-threatening disease strongly associated with risk factors such as e...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-12-089
Budget: 08/01/14 - 07/31/15

DESCRIPTION (provided by applicant): Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis Cardiovascular disease is the leading cause of morbidity and mortality in the United States and is an emerging epidemic world-wide. In particular, atherosclerosis is a life-threatening disease strongly associated with risk factors such as e...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic: PA-12-089
Budget: 08/15/13 - 07/31/14

DESCRIPTION (provided by applicant): Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis Cardiovascular disease is the leading cause of morbidity and mortality in the United States and is an emerging epidemic world-wide. In particular, atherosclerosis is a life-threatening disease strongly associated with risk factors such as e...